U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Industry
  3. FDA Data Standards Advisory Board
  4. Structured Product Labeling Resources
  5. Pharmacokinetic Effect
  1. Structured Product Labeling Resources

Pharmacokinetic Effect

Source: National Cancer Institute Thesaurus

NCI concept code for pharmacokinetic effect consequence: C54354

NCI Thesaurus OID: 2.16.840.1.113883.3.26.1.1

SPL Acceptable Term

Code

INCREASED DRUG LEVEL

C54355

INCREASED DRUG CMAX

C54602

INCREASED DRUG HALF LIFE

C54603

INCREASED DRUG TMAX

C54604

INCREASED DRUG AUC

C54605

DECREASED DRUG LEVEL

C54356

DECREASED DRUG CMAX

C54606

DECREASED DRUG HALF LIFE

C54607

DECREASED DRUG TMAX

C54608

DECREASED DRUG AUC

C54609

INCREASED CONCOMITANT DRUG LEVEL

C54357

INCREASED CONCOMITANT DRUG CMAX

C54610

INCREASED CONCOMITANT DRUG HALF LIFE

C54611

INCREASED CONCOMITANT DRUG TMAX

C54612

INCREASED CONCOMITANT DRUG AUC

C54613

DECREASED CONCOMITANT DRUG LEVEL

C54358

DECREASED CONCOMITANT DRUG CMAX

C54615

DECREASED CONCOMITANT DRUG HALF LIFE

C54616

DECREASED CONCOMITANT DRUG TMAX

C54617

DECREASED CONCOMITANT DRUG AUC

C54614

Back to Top